Could stem cell eye drops finally soothe stubborn dry eyes?

NCT ID NCT05784519

Ongoing Symptom relief Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial tests whether eye drops made from mesenchymal stem cells can safely relieve symptoms in 10 women aged 40-60 with dry eye disease that didn't improve with artificial tears. Participants use the drops twice daily for two weeks and are followed for three months. The study focuses on symptom scores and tear production, but because it's very small and early, results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mesenchymal stem cell eye drops
What this could lead to: If successful, this could point toward a new treatment option for people with dry eye disease that doesn't respond to standard artificial tears.
What could go wrong: This is a very early, small trial with only 10 participants, so results may not apply widely. The treatment is still experimental and its safety and effectiveness are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE SYNDROMES MESENCHYMAL STEM CELL

Contacts and locations

Locations

Drum Tower Hospital Affiliated to Nanjing University

Nanjing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.